Brief: Kalvista Pharma Provides Update On Strong EKTERLY Launch
Jan 8 (Reuters) - Kalvista Pharmaceuticals Inc KALV.O: KALVISTA PHARMACEUTICALS PROVIDES UPDATE ON STRONG EKTERLY® LAUNCH WITH PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 REVENUE RESULTS KALVISTA PHARMACEUTICALS INC - EKTERLY GENERATES $35 MILLION IN Q4 REVENUE Source text: ID:nBw65cXD2a Further company coverage: KALV.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kalvista Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 08:36 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy